The preliminary results from three clinical trials administering gene therapy to address deafness from otoferlin mutations mark inspiring and incredible progress in hearing healthcare.
A hearing healthcare veteran consultant, who has significant hearing loss, describes 7 market-tested best practices. Understanding the consumer-patient journey is crucial to developing strategic priorities for companies across hearing healthcare, from hearing aids to cochlear implants to gene/drug therapy.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Some patients recognize no words at all 12 months after surgery, while others essentially have normal hearing in our analysis. This wide range of speech perception outcomes, we conclude, translates into considerable uncertainty for patients.
Strategies for combating the infiltration of a set of societal beliefs that leads to poor health outcomes is what makes anti-smoking campaigns a compelling analog on the eve of a new OTC hearing aid category.
An overlooked yet central aspect of Apple’s solution is that the AirPods Pro now integrates customized amplification with hearing protection against noise in a single device.
With hearing loss considered to be a social determinant of health, Medicare Advantage payers have taken a more comprehensive approach to hearing healthcare over the last five years. And in turn device makers have responded.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Once the FDA finalizes guidelines, the six global hearing aid companies will face a trajectory familiar to other sectors that have shifted to OTC in the past. They will likely confront dramatically lower prices but also the opportunity to develop the larger market
An important trend contributing to the consumerization of healthcare is the transformation of select prescription categories to over-the-counter.
Hearables point to the potential convergence of traditional hearing aids with consumer product audio devices.
Now that President Trump has signed the Over-The-Counter Hearing Aid Act into law, hearing companies are advancing towards the starting blocks for what's shaping up to be a new race to solve hearing loss.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.